首页|复元通络汤联合常规西药治疗气虚血瘀型急性缺血性卒中患者的效果

复元通络汤联合常规西药治疗气虚血瘀型急性缺血性卒中患者的效果

扫码查看
目的:观察复元通络汤联合常规西药治疗气虚血瘀型急性缺血性卒中(AIS)患者的效果.方法:选取 2021 年 6 月至2023 年 6 月该院收治的 78 例AIS患者进行前瞻性研究,采用随机数字表法将其分为对照组与观察组各 39 例.对照组采用常规西药治疗,观察组在对照组基础上联合复元通络汤治疗,比较两组治疗前后中医证候积分、血液流变学指标水平、炎性指标[白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、单核细胞趋化蛋白-1(MCP-1)]水平、神经功能缺损程度[美国国立卫生研究院卒中量表(NIHSS)]评分和不良反应发生率.结果:治疗后,两组偏身麻木、半身不遂、肢体软弱、气短乏力、心悸自汗、舌歪语蹇等中医证候积分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组全血高切黏度、红细胞聚集指数、血浆黏度、全血低切黏度水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组IL-6、hs-CRP、MCP-1 水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组NHISS评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:复元通络汤联合常规西医治疗气虚血瘀型AIS患者可降低中医证候积分、血液流变学指标水平、炎性指标水平和NIHSS评分,其效果优于单纯常规西药治疗.
Effects of Fuyuan Tongluo decoction combined with conventional western medicine in treatment of patients with acute ischemic stroke of qi deficiency and blood stasis type
Objective:To observe effects of Fuyuan Tongluo decoction combined with conventional western medicine in treatment of patients with acute ischemic stroke(AIS)of qi deficiency and blood stasis type.Methods:A prospective study was conducted on 78 AIS patients admitted to this hospital from June 2021 to June 2023.They were divided into control group and observation group by using the random number table method,39 cases in each group.The control group was treated with conventional western medicine,while the observation group was treated with Fuyuan Tongluo decoction on the basis of that of the control group.The traditional Chinese medicine(TCM)syndrome score,the hemorheology index levels,the inflammatory index[interleukin-6(IL-6),high-sensitivity C-reactive protein(hs-CRP),monocyte chemoattractant protein-1(MCP-1)]levels,the neurological deficit degree[National Institutes of Health stroke scale(NIHSS)]score,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:After the treatment,the scores of TCM syndromes such as partial numbness,hemiplegia,limb weakness,shortness of breath,fatigue,palpitations,spontaneous sweating,deviated tongue and dysphasia in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of whole blood high shear viscosity,erythrocyte aggregation index,plasma viscosity and whole blood low shear viscosity of the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of IL-6,hs-CRP and MCP-1 in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The NHISS scores of the two groups were lower than those before the treatment,that in the observation group was lower than that in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Fuyuan Tongluo decoction combined with conventional western medicine can reduce the TCM syndrome scores,the hemorheology index levels,the inflammatory index levels and the NIHSS scores in the patients with AIS of qi deficiency and blood stasis type.Moreover,it is superior to single conventional western medicine treatment.

Acute ischemic strokeQi deficiency and blood stasis typeFuyuan Tongluo decoctionTCM syndromeHemorheologyNeurological deficit degree

赵彦超、袁佳欢、梁亚锋

展开 >

许昌市人民医院康复医学科,河南 许昌 461000

急性缺血性卒中 气虚血瘀型 复元通络汤 中医证候 血液流变学 神经缺损程度

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(3)
  • 13